MicroRNA 33 Regulates Glucose Metabolism
Open accessAbstract
Metabolic diseases are characterized by the failure of regulatory genes or proteins to effectively orchestrate specific pathways involved in the control of many biological processes. In addition to the classical regulators, recent discoveries have shown the remarkable role of small noncoding RNAs (microRNAs [miRNAs]) in the posttranscriptional regulation of gene expression. In this regard, we have recently demonstrated that miR-33a and miR33b, intronic miRNAs located within the sterol regulatory element-binding protein (SREBP) genes, regulate lipid metabolism in concert with their host genes. Here, we show that miR-33b also cooperates with SREBP1 in regulating glucose metabolism by targeting phosphoenolpyruvate carboxykinase (PCK1) and glucose-6-phosphatase (G6PC), key regulatory enzymes of hepatic gluconeogenesis. Overexpression of miR-33b in human hepatic cells inhibits PCK1 and G6PC expression, leading to a significant reduction of glucose production. Importantly, hepatic SREBP1c/miR-33b levels correlate inversely with the expression of PCK1 and G6PC upon glucose infusion in rhesus monkeys. Taken together, these results suggest that miR-33b works in concert with its host gene to ensure a fine-tuned regulation of lipid and glucose homeostasis, highlighting the clinical potential of miR-33a/b as novel therapeutic targets for a range of metabolic diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SRC1 was up-regulated in miR-33b KI mice, opposite to the results of a previous report.
“SRC1 was up-regulated in miR-33bKI mice and it was opposite to the results of previous report14.”
From MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo (2014) · cites this paper as [14]
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · see citing works
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728 · see citing works
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 6,535 · see citing works
(2008) · doi:10.1038/nrg2290 · Cited by 5,199 · see citing works
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,285 · see citing works
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092 · see citing works
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · see citing works
A pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · see citing works
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · see citing works
Self-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · see citing works
Self-citationCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440 · see citing works
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science · doi:10.1126/science.1189862 · Cited by 1,260 · see citing works
Self-citationRapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S., et al. (2012) · Science · doi:10.1126/science.1215135 · Cited by 1,199 · see citing works
Pervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180 · see citing works
MicroRNAs 103 and 107 regulate insulin sensitivity
Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M. (2011) · Nature · doi:10.1038/nature10112 · Cited by 1,000 · see citing works
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
Najafi-Shoushtari, S. H., Kristo, F., Li, Y., Shioda, T., Cohen, D. E., Gerszten, R. E., & Näär, A. M. (2010) · Science · doi:10.1126/science.1189123 · Cited by 957 · see citing works
The Lin28/let-7 axis regulates glucose metabolism
Zhu, H., Shyh-Chang, N., Segrè, A., Shinoda, G., Shah, S. P., Einhorn, W. S., Takeuchi, A., Engreitz, J. M., Hagan, J., Kharas, M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.033 · Cited by 907 · see citing works
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · see citing works
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 847 · see citing works
Shimomura, I., Bashmakov, Y. K., Ikemoto, S., Horton, J. D., Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13656 · Cited by 779 · see citing works
Foretz, M., Guichard, C., Ferré, P., & Foufelle, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12737 · Cited by 748 · see citing works
Horton, J. D., Shimomura, I., Brown, M. S., Hammer, R. E., Goldstein, J. L., & Shimano, H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2961 · Cited by 703 · see citing works
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
Dávalos, A., Goedeke, L., Smibert, P., Ramírez, C. M., Warrier, N. P., Andreo, U., Cirera-Salinas, D., Rayner, K., Suresh, U., Pastor-Pareja, J. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102281108 · Cited by 670 · cited 1× · see citing works
“It is well established that agonists of LXR, such as oxysterols or insulin, lead to the hepatic induction of SREBP1c and more recently miR-33b (28).”
BackgroundSelf-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652 · see citing works
Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A., & Accili, D. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.006 · Cited by 616 · see citing works
Nakae, J., Biggs, W., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616 · see citing works
Rhee, J., Inoue, Y., Yoon, J. C., Puigserver, P., Fan, M., Gonzalez, F. J., & Spiegelman, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730870100 · Cited by 564 · see citing works
Self-citationmiR-33 links SREBP-2 induction to repression of sterol transporters
Marquart, T. J., Allen, R. M., Ory, D. S., & Baldán, Á. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005191107 · Cited by 562 · see citing works
ADD1/SREBP-1c Is Required in the Activation of Hepatic Lipogenic Gene Expression by Glucose
Foretz, M., Pacot, C., Dugail, I., Lemarchand, P., Guichard, C., Lièpvre, X. L., Lubrano-Berthelier, C., Spiegelman, B. M., Kim, J. B., Ferré, P., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3760 · Cited by 548 · see citing works
Osborne, T. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000017200 · Cited by 521 · see citing works
Laffitte, B. A., Chao, L. C., Li, J., Walczak, R., Hummasti, S., Joseph, S. B., Castrillo, A., Wilpitz, D. C., Mangelsdorf, D. J., Collins, J. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830671100 · Cited by 503 · see citing works
Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
Li, X., Monks, B., Ge, Q., & Birnbaum, M. J. (2007) · Nature · doi:10.1038/nature05861 · Cited by 487 · see citing works
Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs
Frost, R. J., & Olson, E. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118922109 · Cited by 448 · see citing works
Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2
Dentin, R., Liu, Y., Koo, S., Hedrick, S. A., Vargas, T., Heredia, J., Yates, J. R., & Montminy, M. (2007) · Nature · doi:10.1038/nature06128 · Cited by 400 · see citing works
Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*
Gerin, I., Clerbaux, L.-A., Haumont, O., Lanthier, N., Das, A. K., Burant, C. F., Leclercq, I. A., MacDougald, O. A., & Bommer, G. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152090 · Cited by 382 · see citing works
Mutations in the Glucose-6-Phosphatase Gene that Cause Glycogen Storage Disease Type 1a
Lei, K.-J., Shelly, L. L., Pan, C., Sidbury, J. B., & CHOU, J. Y. (1993) · Science · doi:10.1126/science.8211187 · Cited by 377 · see citing works
Schmoll, D., Walker, K. S., Alessi, D. R., Grempler, R., Burchell, A., Guo, S., Walther, R., & Unterman, T. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003616200 · Cited by 349 · see citing works
Hall, R. K., Yamasaki, T., Kučera, T., Waltner-Law, M. E., O’Brien, R. M., & Granner, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004898200 · Cited by 283 · see citing works
Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase
Owen, J., Zhang, Y., Bae, S., Farooqi, M., Liang, G., Hammer, R., Goldstein, J., & Brown, M. S. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1213343109 · Cited by 276 · see citing works
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
Blandino, G., Valerio, M., Cioce, M., Mori, F., Casadei, L., Pulito, C., Sacconi, A., Biagioni, F., Cortese, G., Galanti, S., et al. (2012) · Nature Communications · doi:10.1038/ncomms1859 · Cited by 240 · see citing works
Inactivation of the Glucose 6-Phosphate Transporter Causes Glycogen Storage Disease Type 1b
Hiraiwa, H., Pan, C., Lin, B., MOSES, S. W., & CHOU, J. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5532 · Cited by 165 · see citing works
Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease
Chopra, A. R., Louet, J., Saha, P., An, J., DeMayo, F. J., Xu, J., York, B., Karpen, S. J., Finegold, M. J., Moore, D. D., et al. (2008) · Science · doi:10.1126/science.1164847 · Cited by 161 · see citing works
Yamamoto, T., Shimano, H., Nakagawa, Y., Ide, T., Yahagi, N., Matsuzaka, T., Nakakuki, M., Takahashi, A., Suzuki, H., Sone, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310333200 · Cited by 143 · see citing works
Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis
Rodgers, J. T., Haas, W., Gygi, S. P., & Puigserver, P. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.006 · Cited by 132 · see citing works
The Coactivator SRC-1 Is an Essential Coordinator of Hepatic Glucose Production
Louet, J., Chopra, A. R., Sagen, J. V., An, J., York, B., Tannour‐Louet, M., Saha, P., Stevens, R. D., Wenner, B. R., Ilkayeva, O., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.009 · Cited by 69 · see citing works
The Genomic Analysis of the Impact of Steroid Receptor Coactivators Ablation on Hepatic Metabolism
Jeong, J., Kwak, I., Lee, K. Y., White, L. D., Wang, X., Brunicardi, F. C., O’Malley, B. W., & DeMayo, F. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0407 · Cited by 66 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935 · see citing works
MicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 630 · see citing works
Metabolism of tissue macrophages in homeostasis and pathology
Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A., & Sancho, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00791-9 · Cited by 501 · see citing works
Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
Rahmani, S., Asgary, S., Askari, G., Keshvari, M., Hatamipour, M., Feizi, A., & Sahebkar, A. (2016) · Phytotherapy Research · doi:10.1002/ptr.5659 · Cited by 462 · see citing works
MicroRNA-mediated regulation of glucose and lipid metabolism
Agbu, P., & Carthew, R. W. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00354-w · Cited by 368 · see citing works
MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels
Goedeke, L., Rotllán, N., Canfrán‐Duque, A., Aranda, J. F., Ramírez, C. M., Araldi, E., Lin, C., Anderson, N. N., Wagschal, A., de Cabo, R., et al. (2015) · Nature Medicine · doi:10.1038/nm.3949 · Cited by 270 · see citing works
Self-citationmiRNAs and NAFLD: from pathophysiology to therapy
Gjorgjieva, M., Sobolewski, C., Dolicka, D., de Sousa, M. C., & Foti, M. (2019) · Gut · doi:10.1136/gutjnl-2018-318146 · Cited by 242 · see citing works
Karunakaran, D., Thrush, A. B., Nguyen, M.-A., Richards, L., Geoffrion, M., Singaravelu, R., Ramphos, E., Shangari, P., Ouimet, M., Pezacki, J. P., et al. (2015) · Circulation Research · doi:10.1161/circresaha.117.305624 · Cited by 188 · see citing works
Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis
Tumurkhuu, G., Shimada, K., Dagvadorj, J., Crother, T., Zhang, W., Luthringer, D., Gottlieb, R., Chen, S., & Arditi, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.308362 · Cited by 164 · see citing works
Non-coding RNAs: the new central dogma of cancer biology
Saw, P. E., Xu, X., Chen, J., & Song, E. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1700-9 · Cited by 176 · see citing works
Goedeke, L., Salerno, A., Ramírez, C. M., Guo, L., Allen, R. M., Yin, X., Langley, S. R., Esau, C., Wanschel, A., Fisher, E. A., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404046 · Cited by 145 · see citing works
Self-citationMicromanaging aerobic respiration and glycolysis in cancer cells
Orang, A., Petersen, J., McKinnon, R. A., & Michael, M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.014 · Cited by 115 · see citing works
microRNAs in lipoprotein metabolism and cardiometabolic disorders
Rotllán, N., Price, N. L., Pati, P., Goedeke, L., & Fernandez-Hernando, C. F. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.01.025 · Cited by 111 · see citing works
Self-citationChowdhury, S. R., Reimer, A., Sharan, M., Kozjak‐Pavlovic, V., Eulálio, A., Prusty, B. K., Fraunholz, M. J., Rajeeve, K., & Rudel, T. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201608063 · Cited by 105 · see citing works
Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis
Novák, J., Olejníčková, V., Tkáčová, N., & Santulli, G. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22380-3_5 · Cited by 109 · see citing works
Sefried, S., Häring, H., Weigert, C., & Eckstein, S. S. (2018) · Royal Society Open Biology · doi:10.1098/rsob.180147 · Cited by 97 · see citing works
miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α
Zhou, J., Xu, D., Xie, H., Tang, J., Liu, R., Li, J., Wang, S., Chen, X., Su, J., Zhou, X., et al. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1030545 · Cited by 97 · see citing works
Qiu, Z., Guo, W., Wang, Q., Chen, Z., Huang, S., Zhao, F., Yao, M., Zhao, Y., & He, X. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.050 · Cited by 94 · see citing works
Fernández-de Frutos, M., Galán-Chilet, I., Goedeke, L., Kim, B., Pardo-Marqués, V., Pérez-García, A., Herrero, J. I., Fernández-Hernando, C., Kim, J., & Ramírez, C. M. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00170-19 · Cited by 82 · see citing works
Self-citationMicroRNA-214 Suppresses Gluconeogenesis by Targeting Activating Transcriptional Factor 4
Li, K., Zhang, J., Yu, J., Liu, B., Guo, Y., Deng, J., Chen, S., Wang, C., & Guo, F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.633990 · Cited by 81 · see citing works
Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis
Aryal, B. K., & Suárez, Y. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.03.001 · Cited by 78 · see citing works
Self-citationChanges in microRNA abundance may regulate diapause in the flesh fly, Sarcophaga bullata
Reynolds, J. A., Peyton, J. T., & Denlinger, D. L. (2017) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2017.03.002 · Cited by 77 · see citing works
Kaur, K., Vig, S., Srivastava, R., Mishra, A., Singh, V. P., Srivastava, R., & Datta, M. (2015) · Diabetes · doi:10.2337/db14-1924 · Cited by 75 · see citing works
Micro RNA s: the fine modulators of liver development and function
Chen, Y., & Verfaillie, C. M. (2014) · Liver International · doi:10.1111/liv.12496 · Cited by 74 · see citing works
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases
Aranda, J. F., Madrigal‐Matute, J., Rotllán, N., & Fernandez-Hernando, C. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.014 · Cited by 66 · see citing works
Noncoding RNAs: the shot callers in tumor immune escape
Liu, L., Wang, Q., Qiu, Z., Kang, Y., Liu, J., Ning, S., Yin, Y., Pang, D., & Xu, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0194-y · Cited by 66 · see citing works
MicroRNAs in obesity-associated disorders
Abente, E. J., Subramanian, M., Ramachandran, V., & Najafi-Shoushtari, S. H. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.09.018 · Cited by 63 · see citing works
Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle
Rech, M., Aizpurua, A. B., van Empel, V. P. M., van Bilsen, M., & Schroen, B. L. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy049 · Cited by 61 · see citing works
Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention
Ciaula, A. D., Wang, D. Q. ‐., & Portincasa, P. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1549988 · Cited by 61 · see citing works
Skuratovskaia, D., Vulf, M., Komar, A., Кириенкова, Е. В., & Litvinova, L. S. (2019) · Biomolecules · doi:10.3390/biom9060226 · Cited by 59 · see citing works
SREBP-1c/MicroRNA 33b Genomic Loci Control Adipocyte Differentiation
Price, N., Holtrup, B., Kwei, S. L., Wabitsch, M., Rodeheffer, M. S., Bianchini, L., Suárez, Y., & Fernández-Hernando, C. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00745-15 · Cited by 54 · see citing works
Self-citationCanfrán‐Duque, A., Ramírez, C. M., Goedeke, L., Lin, C., & Fernandez-Hernando, C. F. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu140 · Cited by 58 · see citing works
Self-citationMeuti, M. E., Bautista-Jimenez, R., & Reynolds, J. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203015 · Cited by 55 · see citing works
Relevance of microRNA in metabolic diseases
Price, N., Ramírez, C., & Fernández-Hernando, C. (2014) · Critical reviews in clinical laboratory sciences · doi:10.3109/10408363.2014.937522 · Cited by 52 · see citing works
Self-citationLie, S., Morrison, J. L., Williams-Wyss, O., Suter, C. M., Humphreys, D. T., Ozanne, S. E., Zhang, S., MacLaughlin, S. M., Kleemann, D. O., Walker, S. K., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00553.2013 · Cited by 55 · see citing works
Goyal, N., Sivadas, A., Vellarikkal, S. K., Jayarajan, R., Verma, A., Sivasubbu, S., Scaria, V., & Datta, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-08281-7 · Cited by 56 · see citing works
Perspective: Milk microRNAs as Important Players in Infant Physiology and Development
Leroux, C., Chervet, M., & German, J. B. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab059 · Cited by 55 · see citing works
Reynolds, J. A., Nachman, R. J., & Denlinger, D. L. (2018) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2018.09.013 · Cited by 52 · see citing works
Shi, H., Fang, R., Li, Y., Li, L., Zhang, W., Wang, H., Chen, F., Zhang, S., Zhang, X., & Ye, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.025 · Cited by 52 · see citing works
miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques
Afonso, M. S., Sharma, M., Schlegel, M., van Solingen, C., Koelwyn, G. J., Shanley, L. C., Beckett, L., Peled, D., Rahman, K., Giannarelli, C., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317914 · Cited by 53 · see citing works
Novák, J., Vašků, J. B., Kára, T., & Novák, M. (2014) · Mediators of Inflammation · doi:10.1155/2014/275867 · Cited by 52 · see citing works
Han, S., Han, H., Tian, X., Sun, H., Xue, D., Zhao, C., Jiang, S., He, X., Zheng, W., Wang, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9886 · Cited by 50 · see citing works
Horie, T., Nishino, T., Baba, O., Kuwabara, Y., Nakao, T., Nishiga, M., Usami, S., Izuhara, M., Nakazeki, F., Ide, Y., et al. (2014) · Scientific Reports · doi:10.1038/srep05312 · Cited by 49 · see citing works
Insight into miRNAs related with glucometabolic disorder
Zhang, B., Shen, C., Zhu, B.-W., An, H., Zheng, B. J., Xu, S., Sun, J., Sun, P.-C., Zhang, W., Wang, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.123 · Cited by 47 · see citing works
Role of microRNAs (miRNAs) in the pathophysiology of diabetes mellitus
Tiwari, J., Gupta, G., Pinto, T. D. J. A., Sharma, R., Pabreja, K., Matta, Y., Arora, N., Mishra, A., Sharma, R. K., & Dua, K. (2018) · Panminerva Medica · doi:10.23736/s0031-0808.17.03382-1 · Cited by 45 · see citing works
Gadde, S., & Rayner, K. J. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307481 · Cited by 43 · see citing works
López-Sánchez, G. N., Domínguez‐Pérez, M., Uribe, M., Chávez-Tapia, N. C., & Nuño‐Lámbarri, N. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.04.012 · Cited by 43 · see citing works
Peng, H., Hsiao, J., Chou, S.-T., Hsu, Y.-M., Wu, G.-H., Shieh, Y., & Shiah, S. (2020) · Neoplasia · doi:10.1016/j.neo.2020.08.005 · Cited by 43 · see citing works
MicroRNA regulation of cholesterol metabolism
Citrin, K. M., Fernandez-Hernando, C. F., & Suárez, Y. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14566 · Cited by 44 · see citing works
Self-citationMeng, X., Guo, J., Fang, W., Dou, L., Li, M., Huang, X., Zhou, S., Man, Y., Tang, W., Yu, L., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.713768 · Cited by 42 · see citing works
Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
Yang, D., Sun, L., Li, Z., & Gao, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_7 · Cited by 42 · see citing works
MicroRNA regulation and analytical methods in cancer cell metabolism
Zhang, L.-F., Jiang, S., & Liu, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2508-y · Cited by 40 · see citing works
Ortega, R., Liu, B., & Persaud, S. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310777 · Cited by 41 · see citing works
Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?
Beck, R., Stýblo, M., & Sethupathy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0845-8 · Cited by 39 · see citing works
Zhai, S., Zhao, L., Lin, T. C., & Wang, W. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27961 · Cited by 39 · see citing works
Li, G., Li, Y., & Wang, D. (2020) · Cell Biology International · doi:10.1002/cbin.11476 · Cited by 39 · see citing works
miRNAs in Heart Development and Disease
Lozano-Velasco, E., Inácio, J., Sousa, I., Guimarães, A. R., Franco, D., Moura, G., & Belo, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031673 · Cited by 36 · see citing works
Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33
Allen, R. M., Marquart, T. J., Jesse, J. J., & Baldán, Á. (2014) · Circulation Research · doi:10.1161/circresaha.115.303100 · Cited by 38 · see citing works
Chen, W.-M., Sheu, W., Tseng, P.-C., Lee, T.-S., Lee, W.-J., Chang, P.-J., & Chiang, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154672 · Cited by 34 · see citing works
Wang, Y., Zhou, X., Shan, B., Han, J., Wang, F., Fan, X., Lv, Y., Chang, L., & Liu, W. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4296 · Cited by 36 · see citing works
microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity
Horie, T., Nakao, T., Miyasaka, Y., Nishino, T., Matsumura, S., Nakazeki, F., Ide, Y., Kimura, M., Tsuji, S., Rodriguez, R. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21107-5 · Cited by 49 · see citing works
Suksangrat, T., Phannasil, P., & Jitrapakdee, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12668-1_7 · Cited by 34 · see citing works
miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
Price, N. L., Goedeke, L., Suárez, Y., & Fernández‐Hernando, C. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012606 · Cited by 36 · see citing works
Self-citationPotential role for microRNA in regulating hypoxia-induced metabolic suppression in jumbo squids
Hadj‐Moussa, H., Logan, S. M., Seibel, B. A., & Storey, K. B. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.04.007 · Cited by 30 · see citing works
miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression
Benito‐Vicente, A., Uribe, K. B., Rotllán, N., Ramírez, C. M., Jebari‐Benslaiman, S., Goedeke, L., Canfrán‐Duque, A., Galicia-García, U., de Urturi, D. S., Aspichueta, P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228675 · Cited by 34 · see citing works
Self-citationNon-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases
Formichi, C., Nigi, L., Grieco, G. E., Maccora, C., Fignani, D., Brusco, N., Licata, G., Sebastiani, G., & Dotta, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147716 · Cited by 33 · see citing works
The role of noncoding RNAs in metabolic reprogramming of cancer cells
Safi, A., Saberiyan, M., Sanaei, M., Adelian, S., Asl, F. D., Zeinaly, M., Shamsi, M., & Ahmadi, R. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00447-8 · Cited by 36 · see citing works
MicroRNA-33/33* inhibit the activation of MAVS through AMPK in antiviral innate immunity
Liu, D., Tan, Q., Zhu, J., Zhang, Y., Xue, Y., Song, Y., Liu, Y., Wang, Q., & Lai, L. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0326-x · Cited by 32 · see citing works
Liao, W., Du, J., Wang, Z., Feng, Q., Liao, M., Liu, H., Yuan, K., & Zeng, Y. (2022) · International Journal of Cancer · doi:10.1002/ijc.34040 · Cited by 31 · see citing works
Srivastava, A., Shankar, K., Beg, M., Rajan, S., Gupta, A., Varshney, S., Kumar, D., Gupta, S., Mishra, R. K., & Gaikwad, A. N. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1623-z · Cited by 31 · see citing works
Reimunde, P., Pensado‐López, A., Crende, M. C., Iglesias, V. L., Sanchez, L. E., Torrecilla-Parra, M., Ramírez, C. M., Anfray, C., & Torres, F. (2021) · Cancers · doi:10.3390/cancers13051087 · Cited by 31 · see citing works
Self-citationMMAB promotes negative feedback control of cholesterol homeostasis
Goedeke, L., Canfrán‐Duque, A., Rotllán, N., Chaube, B., Thompson, B. M., Lee, R. G., Cline, G. W., McDonald, J. G., Shulman, G. I., Lasunción, M. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26787-7 · Cited by 30 · see citing works
Self-citationRodil-García, P., Arellanes-Licea, E. D. C., Montoya-Contreras, A., & Salazar‐Olivo, L. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122552 · Cited by 30 · see citing works
Decoding microRNA drivers in atherosclerosis
Vartak, T., Kumaresan, S., & Brennan, E. (2022) · Bioscience Reports · doi:10.1042/bsr20212355 · Cited by 20 · see citing works
Yang, P.-L., Rong, X.-L., Gao, Z., Wang, J.-J., & Liu, Z. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107588 · Cited by 29 · see citing works
miR-194 Promotes Burn-Induced Hyperglycemia via Attenuating IGF-IR Expression
Yu, Y., Chai, J., Zhang, H., Chu, W., Liu, L., Ma, L., Duan, H., Li, B., & Li, D. (2014) · Shock · doi:10.1097/shk.0000000000000258 · Cited by 29 · see citing works
Ye, Z., Li, Y., Liu, G., Qi, X., & Cao, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5355 · Cited by 29 · see citing works
de Almeida-Faria, J., Duque-Guimaraes, D. E., Carpenter, A. A. M., Loche, E., & Ozanne, S. E. (2017) · Scientific Reports · doi:10.1038/srep44949 · Cited by 29 · see citing works
Intersections of post-transcriptional gene regulatory mechanisms with intermediary metabolism
Arif, W., Datar, G. K., & Kalsotra, A. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.01.004 · Cited by 28 · see citing works
Shao, Z., Pan, Q., & Zhang, Y. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105789 · Cited by 28 · see citing works
Epigenetic regulation of inflammatory factors in adipose tissue
Jung, B. C., & Kang, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159019 · Cited by 28 · see citing works
Chang, W., Zhang, L., Xian, Y., & Yu, Z. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4236 · Cited by 27 · see citing works
The role of microRNAs in liver injury at the crossroad between hepatic cell death and regeneration
Lauschke, V. M., Mkrtchian, S., & Ingelman-Sundberg, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.084 · Cited by 29 · see citing works
Refeat, M. M., Hassan, N. A.-M., Ahmad, I. H., Mostafa, E. R. M., & Amr, K. S. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00246-8 · Cited by 24 · see citing works
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression
Fernández-Tussy, P., Cardelo, M. P., Zhang, H., Sun, J., Price, N. L., Boutagy, N. E., Goedeke, L., Cadena-Sandoval, M., Xirouchaki, C. E., Brown, W., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.168476 · Cited by 21 · see citing works
Self-citationCorona-Meraz, F.-I., Mercado, M. V.-D., Ortega, F. J., Ruíz-Quezada, S. L., Guzmán-Ornelas, M.-O., & Navarro-Hernández, R. E. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118816659 · Cited by 22 · see citing works
Noncoding RNAs Carried by Extracellular Vesicles in Endocrine Diseases
Pomatto, M. A. C., Gai, C., Deregibus, M. C., Tetta, C., & Camussi, G. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4302096 · Cited by 22 · see citing works
Xie, R., Cong, X., Zhong, X., Luo, P., Yang, H., Lu, G., Luo, P., Chang, Z., Sun, R., Wu, T., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.7892 · Cited by 21 · see citing works
Frutos, M. F.-D., Pardo, V., Torrecilla-Parra, M., Rada, P., Pérez-García, A., Martín-Martín, Y., de la Peña, G., Gómez, A., Toledano‐Zaragoza, A., Gómez‐Coronado, D., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194938 · Cited by 21 · see citing works
Self-citationKarthi, S., Rajeshwari, M., Francis, A., Matheshwaran, S., Varalakshmi, P., Houlden, H., Kumarasamy Thangaraj, K., & Ashokkumar, B. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.05.016 · Cited by 23 · see citing works
Nutriepigenomics and Malnutrition
Luca, A. D., Hankard, R., Borys, J.-M., Sinnett, D., Marcil, V., & Levy, E. H. (2017) · Epigenomics · doi:10.2217/epi-2016-0168 · Cited by 22 · see citing works
In low protein diets, microRNA-19b regulates urea synthesis by targeting SIRT5
Sun, R.-P., Xi, Q., Sun, J., Cheng, X., Zhu, Y., Ye, D.-Z., Chen, T., Wei, L.-M., Ye, R.-S., Jiang, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep33291 · Cited by 20 · see citing works
Novel role of miR-33 in regulating of mitochondrial function
Price, N., & Fernández-Hernando, C. (2015) · Circulation Research · doi:10.1161/circresaha.117.306949 · Cited by 20 · see citing works
MicroRNA-Management of Lipoprotein Homeostasis
Sun, X., & Feinberg, M. W. (2014) · Circulation Research · doi:10.1161/circresaha.114.304228 · Cited by 19 · see citing works
microRNAs involved in psoriasis and cardiovascular diseases
Sileno, S., Beji, S., D'Agostino, M., Carassiti, A., Melillo, G., & Magenta, A. (2021) · Vascular Biology · doi:10.1530/vb-21-0007 · Cited by 13 · see citing works
Zhao, H., Liu, F., Jia, R., Chang, H., Li, H., Miao, M., Wang, H., & Yang, Z. (2017) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.8671 · Cited by 18 · see citing works
Jia, Q., Cao, Y., Zhang, M., Xing, Y., Xia, T., Guo, Y., Yue, Y.-X., Li, X., Liu, X., Zhang, Y., et al. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103200 · Cited by 17 · see citing works
ΔNp63 intronic miR-944 is implicated in the ΔNp63-mediated induction of epidermal differentiation
Kim, K., Cho, E., Yu, S. J., Kang, H., Kim, Y.-J., Kim, S. H., & Lee, T. R. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv735 · Cited by 17 · see citing works
miRNAs and High-Density Lipoprotein metabolism
Baldán, Á., & Vallim, T. Q. D. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.021 · Cited by 17 · see citing works
Chen, T., Yan, D., Cheng, X., Ji, X., Bian, J., & Yin, W. (2018) · Endocrinology · doi:10.1210/en.2017-03231 · Cited by 16 · see citing works
- Authors
- Ramírez, C. M., Goedeke, L., Rotllan, N., Yoon, J.-H., Cirera-Salinas, D., Mattison, J. A., Suárez, Y., de Cabo, R., Gorospe, M., & Fernández-Hernando, C.
- Affiliations
- New York University (US)
- Departments of Medicine and Cell Biology, Leon H. Charney Division of Cardiology and Marc and Ruti Bell Vascular Biology and Disease Program, New York University School of Medicine, New York, New York, USA
- National Institutes of Health (US)
- Translational Gerontology Branch, National Institute on Aging-Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA
- ORCID
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2013-08-01
- Volume
- 33
- Issue
- 15
- Pages
- 2891-2902
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3719675
- OpenAlex
- W2148995089
- Cited by
- 154
- References
- 46
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 19 · 2020: 12 · 2019: 11 · 2018: 15 · 2017: 16 · 2016: 18 · 2015: 14 · 2014: 13 · 2013: 1
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (F31AG043318)
- National Heart, Lung, and Blood Institute (R01HL105945, R01HL106063, R01HL107953)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Keywords
- miR-33b, miR-33a, SREBP-1c, SREBP1, glucose metabolism, gluconeogenesis, PCK1, glucose-6-phosphatase, hepatic glucose production, post-transcriptional regulation, lipid metabolism, metabolic disorders, therapeutic target
- MeSH terms
- Animals, Gene Expression Regulation, Gluconeogenesis, Glucose, Glucose-6-Phosphatase, Glycogen, Humans, Macaca mulatta, Male, Phosphoenolpyruvate Carboxykinase (GTP), Hepatocytes, MicroRNAs, Intracellular Signaling Peptides and Proteins, Sterol Regulatory Element Binding Protein 1, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review